DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
Top Cited Papers
- 1 November 2011
- journal article
- clinical trial
- Published by Elsevier BV in Genetics in Medicine
- Vol. 13 (11), 913-920
- https://doi.org/10.1097/gim.0b013e3182368a0e
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA SequencingPLOS ONE, 2011
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity studyBMJ, 2011
- Personalized copy number and segmental duplication maps using next-generation sequencingNature Genetics, 2009
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaProceedings of the National Academy of Sciences of the United States of America, 2008
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences of the United States of America, 2008
- ACOG Practice Bulletin No. 88: Invasive Prenatal Testing for AneuploidyObstetrics & Gynecology, 2007
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeThe New England Journal of Medicine, 2005
- Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for ScreeningThe New England Journal of Medicine, 1994
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENThe Lancet, 1986